Terms: = Breast cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3 AND Prognosis
15 results:
1. etv4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.
Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A
Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.
Andradas C; Blasco-Benito S; Castillo-Lluva S; Dillenburg-Pilla P; Diez-Alarcia R; Juanes-García A; García-Taboada E; Hernando-Llorente R; Soriano J; Hamann S; Wenners A; Alkatout I; Klapper W; Rocken C; Bauer M; Arnold N; Quintanilla M; Megías D; Vicente-Manzanares M; Urigüen L; Gutkind JS; Guzmán M; Pérez-Gómez E; Sánchez C
Oncotarget; 2016 Jul; 7(30):47565-47575. PubMed ID: 27340777
[TBL] [Abstract] [Full Text] [Related]
3. Heparanase and COX-2 expression as predictors of lymph node metastasis in large, high-grade breast tumors.
Gawthorpe S; Brown JE; Arif M; Nightingale P; Nevill A; Carmichael AR
Anticancer Res; 2014 Jun; 34(6):2797-800. PubMed ID: 24922641
[TBL] [Abstract] [Full Text] [Related]
4. NOTCH-1 and NOTCH-4 are novel gene targets of pea3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract] [Full Text] [Related]
5. A positive role for pea3 in HER2-mediated breast tumour progression.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
[TBL] [Abstract] [Full Text] [Related]
6. Expression of pea3 and lack of correlation between pea3 and HER-2/neu expression in breast cancer.
Xia WY; Lien HC; Wang SC; Pan Y; Sahin A; Kuo YH; Chang KJ; Zhou X; Wang H; Yu Z; Hortobagyi G; Shi DR; Hung MC
Breast Cancer Res Treat; 2006 Aug; 98(3):295-301. PubMed ID: 16752078
[TBL] [Abstract] [Full Text] [Related]
7. Mediterranean diet, olive oil and cancer.
Colomer R; Menéndez JA
Clin Transl Oncol; 2006 Jan; 8(1):15-21. PubMed ID: 16632435
[TBL] [Abstract] [Full Text] [Related]
8. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and pea3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract] [Full Text] [Related]
9. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
Menendez JA; Vellon L; Mehmi I; Oza BP; Ropero S; Colomer R; Lupu R
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10715-20. PubMed ID: 15235125
[TBL] [Abstract] [Full Text] [Related]
11. The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells.
Tower GB; Coon CI; Brinckerhoff CE
Breast Cancer Res Treat; 2003 Nov; 82(2):75-82. PubMed ID: 14692651
[TBL] [Abstract] [Full Text] [Related]
12. Expression of pea3/e1af/etv4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.
Bièche I; Tozlu S; Girault I; Onody P; Driouch K; Vidaud M; Lidereau R
Carcinogenesis; 2004 Mar; 25(3):405-11. PubMed ID: 14633660
[TBL] [Abstract] [Full Text] [Related]
13. e1af expression levels are not associated with prognosis in human breast cancer.
Span PN; Manders P; Heuvel JJ; Beex LV; Sweep CG
Breast Cancer Res Treat; 2003 May; 79(1):129-31. PubMed ID: 12779089
[TBL] [Abstract] [Full Text] [Related]
14. Targeting HER2: recent developments and future directions for breast cancer patients.
Wang SC; Zhang L; Hortobagyi GN; Hung MC
Semin Oncol; 2001 Dec; 28(6 Suppl 18):21-9. PubMed ID: 11774202
[TBL] [Abstract] [Full Text] [Related]
15. [Transcription factors of the pea3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract] [Full Text] [Related]